Allergan’s Aesthetic Device Lineup Gains Momentum In 2nd Quarter
This article was originally published in The Gray Sheet
Executive Summary
Allergan's core device sales soared 53.6% in the second quarter from a year ago to $197 million, building momentum for the firm's medical aesthetic products in "rapidly expanding markets," the firm reported Aug. 1